Sarbay İsmail
Sinop Ataturk Public Hospital Thoracic Surgery, Sinop, Turkey.
Kardiochir Torakochirurgia Pol. 2024 Dec;21(4):201-205. doi: 10.5114/kitp.2024.145870. Epub 2024 Dec 13.
Introduction Smoking cessation remains a global challenge due to the complex and individualized nature of addiction. Understanding the interplay of psychological, social, and biological factors is crucial for developing effective, personalized cessation strategies.
This study investigated the factors influencing the success of smoking cessation efforts among patients visiting thoracic surgery outpatient clinics.
Between October 2022 and October 2023, 355 smokers sought assistance at thoracic surgery outpatient clinics, with 231 patients included in the study after exclusions. Data on demographics, comorbidities, cessation attempts, and Fagerström addiction scores were analyzed. Patients received nicotine replacement therapy (NRT), medical therapy (bupropion), and behavioral therapy. Follow-ups were conducted at 1, 3, and 6 months to assess cessation outcomes.
The cohort included 137 males and 94 females, with an average age of 45 years. Overall, 81 patients (35.06%) quit smoking in the first month, and 15 (6.49%) additional patients quit by the third month. Relapse occurred in 36 (15.58%) patients, and 99 (42.86%) patients failed to quit. Success rates were similar between genders and unrelated to age, comorbidities, previous attempts, or smoking intensity. The success rate was slightly higher among those who received pharmacotherapy, but the difference was not statistically significant. However, full adherence to behavioral suggestions was significantly associated with increased cessation success ( < 0.001).
Behavioral therapy plays a critical role in smoking cessation success. Tailored behavioral strategies significantly enhance outcomes, highlighting the need for personalized approaches in cessation programs. Patients in thoracic surgery outpatient clinics benefit from comprehensive support, emphasizing behavioral adaptation to improve cessation rates.
引言 由于成瘾的复杂性和个体差异性，戒烟仍然是一项全球性挑战。了解心理、社会和生物学因素之间的相互作用对于制定有效的个性化戒烟策略至关重要。
本研究调查了影响胸外科门诊患者戒烟努力成功的因素。
2022年10月至2023年10月期间，355名吸烟者在胸外科门诊寻求帮助，排除后231名患者纳入研究。分析了人口统计学、合并症、戒烟尝试和法格斯特罗姆成瘾评分数据。患者接受尼古丁替代疗法（NRT）、药物治疗（安非他酮）和行为疗法。在1、3和6个月进行随访以评估戒烟结果。
该队列包括137名男性和94名女性，平均年龄45岁。总体而言，81名患者（35.06%）在第一个月戒烟，另外15名患者（6.49%）在第三个月戒烟。36名患者（15.58%）复发，99名患者（42.86%）戒烟失败。男女成功率相似，且与年龄、合并症、既往尝试或吸烟强度无关。接受药物治疗的患者成功率略高，但差异无统计学意义。然而，完全遵守行为建议与戒烟成功率增加显著相关（<0.001）。
行为疗法在戒烟成功中起关键作用。量身定制的行为策略显著提高了戒烟效果，凸显了戒烟计划中采用个性化方法的必要性。胸外科门诊患者受益于全面支持，强调行为调整以提高戒烟率。
